بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant 17 » significant _ (توسيع البحث), significant co (توسيع البحث), significant gap (توسيع البحث)
17 decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant 17 » significant _ (توسيع البحث), significant co (توسيع البحث), significant gap (توسيع البحث)
17 decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
-
2821
-
2822
-
2823
-
2824
-
2825
-
2826
-
2827
-
2828
-
2829
-
2830
Flowchart of analysis.
منشور في 2025"…</p><p>Results</p><p>A total of 168,693 primary KA patients were included during the study period. The migration rate decreased from 17.6% in 2013 to 7.6% in 2018 (<i><i>P</i></i> < 0.001). …"
-
2831
-
2832
-
2833
-
2834
-
2835
Study flow chart.
منشور في 2025"…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…"
-
2836
Bar graph showing proportion of NADCs.
منشور في 2025"…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…"
-
2837
Baseline characteristics of study participants.
منشور في 2025"…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…"
-
2838
-
2839
-
2840